Professor Catriona Bradshaw [MMBS(Hons), FAChSHM, PhD] is a clinician researcher and Head of Research Translation and Mentorship and of The Genital Microbiota and Mycoplasma Group at Melbourne Sexual Health Centre, Central Clinical School, Monash University and Alfred Hospital. Her programme focuses on translational research to improve treatment & control of STIs, particularly Mycoplasma genitalium, an STI which has developed resistance to available therapies, and bacterial vaginosis (BV), a common dysbiosis that is refractory to current treatment and associated with adverse reproductive and sexual health outcomes. She has >15 years’ experience in clinical and epidemiological research on BV and the vaginal microbiota, having recruited over 3000 women to RCTs and large prospective studies to understand the pathogenesis of BV and develop interventions to improve cure and restore an optimal vaginal microbiota to promote reproductive health. Her group is currently undertaking an NHMRC funded multicentre male partner treatment trial for women with BV (CIA) and if effective, this strategy will have a global impact providing opportunities for the first time for long-term control and prevention of BV and its sequelae. Catriona’s group is part of the MRFF Frontiers funded EVE-M initiative to develop multipurpose prevention technologies to improve sexual and reproductive health for women and the ARC Industrial Translation Research Hub to Combat AMR with a focus on new diagnostics and antimicrobials to combat STIs. Catriona has a strong track record of translating findings into policy and practice with >300 publications and has been an investigator on NHMRC, MRFF Frontier Health, ARC, Victorian Medical Research Acceleration Fund, university and industry grants. She has been a member of national and international STI guideline committees, an elected board member of the International Society for STD Research and a recipient of a L'Oréal-UNESCO Women in Science Award.